key: cord-1025357-7l0jvgh8 authors: Meinhardt, Jenny; Radke, Josefine; Dittmayer, Carsten; Mothes, Ronja; Franz, Jonas; Laue, Michael; Schneider, Julia; Brünink, Sebastian; Hassan, Olga; Stenzel, Werner; Windgassen, Marc; Rößler, Larissa; Goebel, Hans-Hilmar; Martin, Hubert; Nitsche, Andreas; Schulz-Schaeffer, Walter J.; Hakroush, Samy; Winkler, Martin S.; Tampe, Björn; Elezkurtaj, Sefer; Horst, David; Oesterhelweg, Lars; Tsokos, Michael; Heppner, Barbara Ingold; Stadelmann, Christine; Drosten, Christian; Corman, Victor Max; Radbruch, Helena; Heppner, Frank L. title: Olfactory transmucosal SARS-CoV-2 invasion as port of Central Nervous System entry in COVID-19 patients date: 2020-06-04 journal: bioRxiv DOI: 10.1101/2020.06.04.135012 sha: 56ac9967d30742c1d6b2b697001f01c5cb1c90a0 doc_id: 1025357 cord_uid: 7l0jvgh8 The newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a pandemic respiratory disease presenting with fever, cough, and often pneumonia. Moreover, thromboembolic events throughout the body including the central nervous system (CNS) have been described. Given first indication for viral RNA presence in the brain and cerebrospinal fluid and in light of neurological symptoms in a large majority of COVID-19 patients, SARS-CoV-2-penetrance of the CNS is likely. By precisely investigating and anatomically mapping oro- and pharyngeal regions and brains of 32 patients dying from COVID-19, we not only describe CNS infarction due to cerebral thromboembolism, but also demonstrate SARS-CoV-2 neurotropism. SARS-CoV-2 enters the nervous system via trespassing the neuro-mucosal interface in the olfactory mucosa by exploiting the close vicinity of olfactory mucosal and nervous tissue including delicate olfactory and sensitive nerve endings. Subsequently, SARS-CoV-2 follows defined neuroanatomical structures, penetrating defined neuroanatomical areas, including the primary respiratory and cardiovascular control center in the medulla oblongata. There is increasing evidence that the SARS-CoV-2 not only affects the respiratory tract but 55 also impacts the CNS resulting in neurological symptoms such as loss of smell and taste, headache, 56 fatigue, nausea and vomiting in more than one third of COVID-19 patients 1, 2 . Moreover, acute 57 cerebrovascular diseases and impaired consciousness have been described 3 . While recent studies 58 describe the presence of viral RNA in the brain and cerebrospinal fluid (CSF) 4,5 but lack a prove for 59 genuine SARS-CoV-2 manifestation, a systematic analysis of COVID-19 autopsy brains aimed at 60 understanding the port of SARS-CoV-2 entry and distribution within the CNS is lacking 6 . 61 The neuroinvasive potential of evolutionarily-related coronaviruses (CoVs) such as SARS-CoV 62 and MERS-CoV has previously been described [7] [8] [9] . SARS-CoV including SARS-CoV-2 enter human host 63 cells primarily by binding to the cellular receptor angiotensin-converting enzyme 2 (ACE2) and by the 64 action of the serine protease TMPRSS2 for S protein priming 10 . Supporting evidence comes from 65 animal studies demonstrating that SARS-CoV is capable of entering the brain upon intranasal 66 infection of mice expressing human ACE2 8, 11 . However, it is not known, which cells in the olfactory 67 mucosa express these molecules in steady state or under inflammatory or septic conditions 11 , while 68 there is first evidence for ACE2 expression in neuronal and glial cells in the CNS 13,14 . Along that line it 69 is of note, that the immunoglobulin superfamily member CD147, which is expressed in neuronal and 70 non-neuronal cells in the CNS 15,16 , has been shown to act as alternative cellular port for SARS-CoV-2 71 invasion 17 . To gain a better understanding of SARS-CoV-2 neurotropism and its mechanism of CNS 72 entry and distribution, we analyzed the cellular mucosal-nervous micro-milieu as first site of viral 73 infection and replication, followed by a thorough regional mapping of the consecutive olfactory 74 nervous tracts and defined CNS regions in 32 COVID-19 autopsy cases. 75 Out of 32 COVID-19 autopsy cases, either proven to be RT-qPCR-positive for SARS-CoV-2 78 prior to death (N=29 of 32), or with clinical presentation highly suggestive of COVID-19 (N=3 of 32), 79 four patients (corresponding to 13%) presented with acute infarction due to ischemia caused by 80 (micro)thrombotic/thromboembolic events within the CNS (Supplementary Table 1 ). Similarly, 81 microthrombotic events were also detectable in the olfactory mucosa (Supplementary Figure 1) . 82 Table 1 ). Patients with shorter disease duration were more likely to be tested 94 positive for viral RNA in the CNS tissue (Supplementary Table 1 We provide first evidence that SARS-CoV-2 neuroinvasion occurs at the neuro-mucosal 120 interface by transmucosal trespassing via regional nervous structures followed by a transport along 121 the olfactory tract of the CNS, thus explaining some of the well-documented neurological symptoms 122 in COVID-19 patients including alterations of smell and taste perception. Further studies are required 123 to identify the precise cellular and molecular entry mechanism as well as receptors in the olfactory 124 mucosa, where also non-neuronal pathways may play a role 26 . This will include a precise 125 characterization of ACE2, TMPRSS2 and of CD147 expression, which have been implicated in enabling 126 SARS-CoV-2 invasion in cells. Moreover, in line with recent clinical data demonstrating 127 thromboembolic CNS events described in few patients 27 , we found in 13% of the 32 investigated 128 cases also the histopathological correlate of microthrombosis and territorial brain infarcts. 129 The presence of genuine virus in the olfactory mucosa with its delicate olfactory and Clinical features of patients infected with 2019 novel coronavirus in Wuhan Neurotropism of SARS-CoV 2: Mechanisms and manifestations Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Multiorgan and Renal Tropism of SARS-CoV-2 A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Neuropathologists play a key role in establishing the extent of COVID-19 in human 258 patients Mechanisms of host defense following 261 severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and 264 Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4 Severe acute respiratory 267 syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice 268 transgenic for human ACE2 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a 270 Differential expression of neuronal ACE2 in transgenic mice with 272 overexpression of the brain renin-angiotensin system The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and 277 mouse brain Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the 280 Age of Coronavirus Disease 2019: A Review How, with whom and when: an overview of CD147-mediated 283 regulatory networks influencing matrix metalloproteinase activity The dynamics of CD147 in Alzheimer's disease development and pathology SARS-CoV-2 invades host cells via a novel route: CD147-spike protein The olfactory nerve: a shortcut for influenza and other viral 291 diseases into the central nervous system DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation 293 during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway Endothelial cell infection and endotheliitis in COVID-19 Electron microscopy of 298 SARS-CoV-2: a challenging task Ultrastructural characterization of SARS coronavirus Modern uses of electron microscopy for detection of viruses A novel coronavirus associated with severe acute respiratory syndrome The basement membrane underneath the columnar AE1/3-positive epithelium (F, red color) is 371 discontinued due to CD56-positive (F, brown color) axonal projections of ORNs (F, arrow). The ORN 372 dendrite carries multiple cilia and protrudes into the nasal cavity (G, semithin section, toluidine blue 373 staining), while the axon (H, arrowhead) crosses the olfactory mucosa basement membrane (H, 374 arrows) as a precondition for ORN projection into the glomeruli of the olfactory bulb with the osseous cribriform plate (turquoise color and asterisk in B, pink color and asterisk in C) and 362 the close anatomical proximity of the olfactory mucosa (green in B, purple in C) and nervous tissue 363 characterized by nerve fibers immunoreactive for S100 protein (C, brown color). Cartoon (D) 364 resembling the olfactory mucosa, which is composed of pseudostratified ciliated columnar 365 epithelium, basement membrane, and lamina propria, also containing mucus-secreting Bowman 366 glands and bipolar olfactory receptor neurons (ORNs), which coalesce the epithelial layer.